Stay updated with breaking news from Sam Purewal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investment will enable pHion to progress its lead program into the clinic Transaction builds on invoX's initial investment in 2021 invoX Pharma Limited ("invoX")a U.K.-based wholly-owned subsidiary
Investment will enable pHion to progress its lead program into the clinicTransaction builds on invoX’s initial investment in 2021LONDON--(BUSINESS WIRE)--invoX Pharma Limited (“invoX”), a U.K.-based wholly-owned subsidiary of Sino Biopharmaceutical Limited (“Sino Biopharm”) (HKEX 1177 HK) with an advancing pipeline...
Investegate announcements from Medica Group PLC, Publication of Annual Financial Report
invoX Pharma Limited ("invoX"), a U.K.-based wholly-owned subsidiary of Sino Biopharmaceutical Limited ("Sino Biopharm") (HKEX 1177 HK) with an advancing pipeline of innovative products, today announces
LONDON, Jan. 26, 2023 (GLOBE NEWSWIRE) -- invoX Pharma ("invoX"), a wholly owned subsidiary of Sino Biopharmaceutical Limited ("Sino Biopharm") (HKEX 1177 HK), and F-star Therapeutics, Inc. ("F-star")